Organization of antibiotic amphotericin B in model lipid membranes. A mini review

被引:0
|
作者
Gruszecki, WI
Gagos, M
Herec, M
Kernen, P
机构
[1] Marie Curie Sklodowska Univ, Inst Phys, Dept Biophys, PL-20031 Lublin, Poland
[2] Univ Agr, Dept Phys, Lublin, Poland
[3] Zyomyx Inc, Hayward, CA 94545 USA
关键词
amphotericin B; molecular aggregates; lipid membranes;
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Amphotericin B (Am]3) is a polyene antibiotic frequently applied in the treatment of fungal infections. According to the general understanding, the mode of action of AmB is directly related to the molecular organization of the drug in the lipid environment, in particular to the formation of pore-like molecular aggregates. Electronic absorption and fluorescence techniques were applied to investigate formation of molecular aggregates of AmB in the lipid environment of liposomes and monomolecular layers formed at the argon-water interface. It appears that AmB dimers, stabilized by van der Waals interactions, are present in the membrane environment along with the aggregates formed by a greater number of molecules. Linear dichroism measurements reveal that AmB is distributed between two fractions of molecules, differently oriented with respect to the bilayer. Molecules in one fraction remain parallel to the plane of the membrane and molecules in the other one are perpendicular. Scanning Force Microscopy imaging of the surface topography of the monolayers formed with AmB in the presence of lipids reveals formation of pore-like structures characterized by the external diameter close to 17 Angstrom and the internal diameter close to 6 Angstrom. All the findings are discussed in terms of importance of the molecular organization of AmB in the pharmacological action, as well as of the toxic side effects of the drug.
引用
收藏
页码:161 / 170
页数:10
相关论文
共 50 条
  • [31] ANATOMY OF AMPHOTERICIN-B-CHOLESTEROL PORES IN LIPID BILAYER MEMBRANES
    ANDREOLI, TE
    KIDNEY INTERNATIONAL, 1973, 4 (05) : 337 - 345
  • [32] Transient permeability induced by cationic derivatives of amphotericin B in lipid membranes
    Kasumov, K
    Bolard, J
    POLISH JOURNAL OF CHEMISTRY, 2004, 78 (08) : 1057 - 1065
  • [33] How Does the Antibiotic Amphotericin B Enter Membranes and What Does It Do There?
    Janik, Sebastian
    Luchowski, Rafal
    Grela, Ewa
    Grudzinski, Wojciech
    Gruszecki, Wieslaw I.
    JOURNAL OF PHYSICAL CHEMISTRY LETTERS, 2024, 15 (18): : 4823 - 4827
  • [34] INTERACTION BETWEEN PHOSPHOLIPID-BILAYER MEMBRANES AND THE POLYENE ANTIBIOTIC AMPHOTERICIN-B - LIPID STATE AND CHOLESTEROL CONTENT DEPENDENCE
    BOLARD, J
    SEIGNEURET, M
    BOUDET, G
    BIOCHIMICA ET BIOPHYSICA ACTA, 1980, 599 (01) : 280 - 293
  • [35] INTERACTION OF THE POLYENE ANTIBIOTIC AMPHOTERICIN-B WITH MODEL MEMBRANES - DIFFERENCES BETWEEN SMALL AND LARGE UNILAMELLAR VESICLES
    MILHAUD, J
    HARTMANN, MA
    BOLARD, J
    BIOCHIMIE, 1989, 71 (01) : 49 - 56
  • [36] Antibiotic interactions using liposomes as model lipid membranes
    Pinheiro, Marina
    Magalhaes, Joana
    Reis, Salette
    CHEMISTRY AND PHYSICS OF LIPIDS, 2019, 222 : 36 - 46
  • [37] Pharmacokinetics and Pharmacodynamics of Amphotericin B Deoxycholate, Liposomal Amphotericin B, and Amphotericin B Lipid Complex in an In Vitro Model of Invasive Pulmonary Aspergillosis
    Lestner, Jodi M.
    Howard, Susan J.
    Goodwin, Joanne
    Gregson, Lea
    Majithiya, Jayesh
    Walsh, Thomas J.
    Jensen, Gerard M.
    Hope, William W.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2010, 54 (08) : 3432 - 3441
  • [38] Comparative Pharmacodynamics of Amphotericin B Lipid Complex and Liposomal Amphotericin B in a Murine Model of Pulmonary Mucormycosis
    Lewis, Russell E.
    Albert, Nathan D.
    Liao, Guangling
    Hou, Jingguo
    Prince, Randall A.
    Kontoyiannis, Dimitrios P.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2010, 54 (03) : 1298 - 1304
  • [39] Amphotericin B lipid complex: Review of safety, pharmacokinetics and efficacy
    Dix, SP
    Wingard, JR
    DRUGS OF TODAY, 1996, 32 : 19 - 25
  • [40] Amphotericin B lipid complex: Review of safety, pharmacokinetics and efficacy
    Dix, SP
    Wingard, JR
    DRUGS OF TODAY, 1996, 32 (05): : 411 - 416